Patheon has announced that Dr Marshall Crew, vice-president, global PDS scientific excellence, has been named one of the top 100 most influential people in drug development and manufacturing by the publication the Medicine Maker.
Dr Crew, a scientist and expert in low-solubility drug formulation, was previously the founder of Agere Pharmaceuticals, a CDMO specialising in oral bioavailability of insoluble molecules that was acquired by Patheon.
Dr Crew’s career has been devoted to improving the delivery of poorly soluble drugs through innovation and technology. He has nearly 30 patents and patent applications filed under his name.
Dr Crew said: "It is an honour to be included among such an accomplished group.
"As a community, I’m optimistic that we will see many more advances realised by these accomplished scientists, engineers and healthcare professionals, who are working relentlessly toward driving positive change for the critical needs of patients."
UK-based The Medicine Maker is a monthly publication with a focus on clinical, regulatory, development and manufacturing fields for biopharmaceuticals.
The publication’s readers nominate individuals to the annual Power List, which is selected and ranked by an independent jury.